Next Generation Sequencing Market Growth Projection: Expected to Surpass $28.59 Billion by 2030 at 15.1% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Next Generation Sequencing Market’s size between 2026 and 2030?
The valuation of the next generation sequencing market has expanded quickly in recent times. Projections indicate it will increase from $14.2 billion in 2025 to $16.31 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 14.9%. This historical expansion is attributable to several factors, including heightened research efforts in genomics, reduced expenses associated with sequencing technologies, the proliferation of molecular diagnostics laboratories, a growing need for genetic analysis linked to diseases, and the accessibility of sophisticated sequencing reagents.
The next generation sequencing market size is anticipated to undergo significant expansion in the coming years. It is projected to reach $28.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period is attributable to the increasing embrace of precision medicine initiatives, rising investments in population genomics studies, the broader application of NGS in oncology diagnostics, an escalating demand for swift sequencing solutions, and the enhanced integration of sequencing data with clinical decision systems. Prominent trends for the forecast period involve the increasing adoption of high-throughput sequencing platforms, a rising need for clinical diagnostic sequencing, the growing incorporation of AI-based bioinformatics tools, the expansion of targeted and personalized medicine applications, and an intensified focus on cost-effective sequencing workflows.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3990&type=smp
Which Drivers Are Shaping Strategic Decisions In The Next Generation Sequencing Market?
The escalating demand for personalized medicine is projected to stimulate the expansion of the next-generation sequencing market moving forward. Personalized medicine, alternatively known as precision medicine, constitutes a novel method in medical treatment and healthcare that considers a person’s distinctive genetic, environmental, and lifestyle elements to customize medical choices and therapies. Next-generation sequencing serves as an essential technology within personalized medicine, facilitating the precise analysis of an individual’s genetic composition and the formulation of bespoke healthcare strategies. For instance, in February 2024, the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that the FDA sanctioned 16 new personalized treatments for rare disease patients in 2023, which is an increase from 6 in 2022. This demonstrates how the heightened requirement for personalized medicine is consequently propelling the growth of the next-generation sequencing market.
What Segment Classifications Make Up The Next Generation Sequencing Market?
The next generation sequencing market covered in this report is segmented –
1) By Product: Instruments, Reagents And Kits, Software
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies
3) By Application: Diagnostics, Drug Discovery, Other Applications
Subsegments:
1) By Instruments: Sequencing Systems, Library Preparation Instruments, Quality Control Instruments
2) By Reagents And Kits: Sequencing Reagents, Library Preparation Kits, Amplification Kits
3) By Software: Data Analysis Software, Bioinformatics Software, Workflow Management Software
Which Trends Are Guiding The Evolution Of The Next Generation Sequencing Market?
Leading companies in the next-generation sequencing market are concentrating on developing advanced solutions, such as hybrid long- and short-read sequencing, to improve genomic resolution and accuracy. This hybrid approach combines the high throughput and low error rates characteristic of short reads with the benefits of structural insight and extensive coverage from long reads. For example, in March 2023, Illumina, a US-based biotechnology firm, introduced the Illumina Complete Long Read Prep, Human assay, which features its innovative Complete Long Read technology. This assay facilitates both long- and short-read data generation on the same Illumina instrument and is specifically compatible with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Key functionalities include a more straightforward workflow with considerably reduced DNA input needs compared to other long-read platforms, the integration of Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis for highly accurate whole-genome sequencing, access to challenging and difficult-to-map genic regions, and a promotional price of US $1,350 per genome (on NovaSeq X Plus with a 25B flow cell), which covers long- and short-read library preparation, sequencing, and cloud analysis.
Which Major Industry Participants Are Leading The Next Generation Sequencing Market Growth?
Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio-Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Which Geographic Areas Are Emerging As Strong Markets For The Next Generation Sequencing Market?
North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Next Generation Sequencing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3990&type=smp
Browse Through More Reports Similar to the Global Next Generation Sequencing Market 2026, By The Business Research Company
Clinical Oncology Next Generation Sequencing Global Market Report 2026
Clinical Next Generation Sequencing Ngs Data Analysis Global Market Report 2026
Dna Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
